Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional Oculofacial Abstracts.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Severe Congenital Ptosis Repair: A Report by the American Academy of Ophthalmology.

Ophthalmology·2026
Same author

The Role of Corticosteroids in the Management of Orbital Cellulitis: A Report by the American Academy of Ophthalmology.

Ophthalmology·2026
Same author

From pixels to precision: Imaging technologies shaping oculofacial plastic surgery practice.

Taiwan journal of ophthalmology·2026
Same author

Safety Analysis of Oxymetazoline Eye Drops for Blepharoptosis Using the FDA Adverse Event Reporting System.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Social Determinants of Health Associated with Orbital and Facial Fractures in the United States using National Institutes of Health All of Us Research Program.

Ophthalmology·2026

Related Experiment Video

Updated: Jun 3, 2026

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction
06:32

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction

Published on: December 5, 2025

Enduragen patch grafts for exposed orbital implants.

Albert Y Wu1, M Reza Vagefi, Dan Georgescu

  • 1University of Utah Moran Eye Center, Salt Lake City, UT, USA. albertyapowu@gmail.com

Orbit (Amsterdam, Netherlands)
|March 29, 2011
PubMed
Summary
This summary is machine-generated.

This study shows Enduragen material is a safe and effective patch graft for exposed ocular implants. Further research is recommended to define its full potential in orbital implant care.

More Related Videos

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Related Experiment Videos

Last Updated: Jun 3, 2026

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction
06:32

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction

Published on: December 5, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Area of Science:

  • Ophthalmology
  • Biomaterials Science

Background:

  • Exposed ocular implants pose a significant challenge in orbital reconstructive surgery.
  • Current management strategies for exposed implants often involve complex reconstructive procedures.

Observation:

  • This case series evaluated the use of Enduragen, a novel biomaterial, as a patch graft for exposed ocular implants.
  • Three patients with exposed orbital implants underwent repair using Enduragen patch grafts.

Findings:

  • Enduragen patch grafts were successfully used to cover exposed ocular implants in all three patients.
  • No implant re-exposure or significant complications were observed during a mean follow-up of 41.3 months.
  • The material facilitated closure of Tenon's capsule and conjunctiva over the implants.

Implications:

  • Enduragen demonstrates potential as a safe and effective option for managing exposed orbital implants.
  • Larger prospective studies are warranted to establish definitive indications and limitations for Enduragen in orbital implant reconstruction.